Loading...
Back to narrative

ELE: Margin Normalization And Sector Rotation Will Shape Future Return Profile

Update shared on 13 Dec 2025

Fair value Increased 2.86%
n/a
n/a
AnalystConsensusTarget's Fair Value
n/a
Loading
1Y
49.8%
7D
-0.6%

Analysts have nudged their fair value estimate for Endesa higher to approximately EUR 27.94 from about EUR 27.16, reflecting slightly stronger expected revenue growth and a modestly richer future earnings multiple, even as they factor in normalizing electricity and gas margins along with a less favorable stance on traditional generators.

Analyst Commentary

Recent research updates signal a more cautious stance on Endesa, with several valuation frameworks resetting to reflect normalizing commodity spreads and a less favorable view on conventional generation relative to renewables focused peers.

Bearish Takeaways

  • Bearish analysts argue that Endesa screens expensive versus the broader utilities group, particularly when benchmarked against companies with larger, faster growing renewables portfolios.
  • There is concern that electricity and gas margins, currently at historically elevated levels, will normalize over the next few years, reducing earnings power and justifying lower target prices.
  • Shifts in European sector preferences toward renewables and away from traditional generators are seen as a structural headwind for Endesa's valuation multiple and relative share price performance.
  • Some forecasts now embed lower upside potential to prior price targets, reflecting a view that execution on growth and capital allocation may not be sufficient to offset margin compression and sector rotation.

What's in the News

  • Endesa confirmed its earnings guidance for 2025, stating it is on track to reach the upper end of its net income forecast, supported by current results that align with prior expectations (Key Developments).
  • The company reiterated that it expects to achieve the top end of its Capital Market Day guidance for full year 2025, signaling confidence in its operational and financial trajectory (Key Developments).

Valuation Changes

  • Fair Value Estimate has risen slightly from approximately €27.16 to about €27.94 per share, implying a modest uplift in long term expectations.
  • Discount Rate is unchanged at 7.65 percent, indicating no shift in the assumed cost of capital or risk profile.
  • Revenue Growth has increased slightly from roughly 4.61 percent to about 4.83 percent annually, reflecting a marginally stronger top line outlook.
  • Net Profit Margin has edged down slightly from around 8.23 percent to about 8.20 percent, suggesting a small expected dilution in profitability.
  • Future P/E multiple has risen modestly from about 16.9x to roughly 17.3x, pointing to a slightly richer valuation assumption for Endesa's earnings stream.

Have other thoughts on Endesa?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.